Cancer/Oncology

Active Projects: 138

Project	Investigator	All Topics	Start date	End date
Pre-B Cell Receptor Signaling in Acute Lymphoblastic Leukemia	Markus Muschen, MD, PhD	Cancer/Oncology	2/1/14	1/31/19
Systems-level role of GSK3 in colonic epithelium homeostasis and drug resistance	Steven Altschuler, PhD	Cancer/Oncology, Diet, Exercise, and Obesity	2/1/15	1/31/19
Thai Red Cross S&S, HPV TA008	Joel Palefsky, MD	Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology, Pharmacology and Drug Treatment	2/1/14	1/31/19
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects with INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma		Cancer/Oncology	2/1/16	1/31/19
UCSF Team, The genetic, epigenetic, and immunological underpinnings of cancer evolution through treatment	Steven Altschuler, PhD	Cancer/Oncology, Genetics	2/1/16	2/1/19
Establishment of a Philippine Cancer Phenome-Biobanking System	Linda Giudice, MD, PhD, MSc	Cancer/Oncology	3/1/17	2/28/19
Latino Community Education Tool on Hereditary Breast Cancer	Laura Fejerman, PhD	Cancer/Oncology, Women's Health, Patient and Peer Education	9/1/17	2/28/19
Advanced breast imaging: trends and outcomes associated with recent breast density reporting legislation	Karla Kerlikowske, MD	Cancer/Oncology, Women's Health	3/15/17	2/28/19
Reducing Breast Cancer Risk in Korean American Women	Janice Tsoh, PhD	Cancer/Oncology, Genetics, Immigration and Migration	9/1/18	2/28/19
Epigenetic Regulation of Pancreatic Cancer	Matthias Hebrok, PhD	Cancer/Oncology	4/3/14	2/28/19
ARID5B and Disparities of Childhood Leukemia	Mignon Loh, MD	Cancer/Oncology, Pediatrics	5/1/14	4/30/19
Phase 3 trial Of Fulvestrant with or without Palbociclib +/- Goserelin in women with hormone receptor-positive, Her2-negative metastatic breast cancer whose disease progressed after prior endocrine therapy	Hope Rugo, MD	Cancer/Oncology, Women's Health	5/28/14	4/30/19
Impact of Low IL-10 Levels at Birth and Leukemia Risk	Joseph Wiemels, PhD	Cancer/Oncology, Immunology	6/1/14	5/31/19
Risk-based Breast Cancer Screening and Surveillance in Community Practice	Karla Kerlikowske, MD	Cancer/Oncology, Women's Health	7/1/17	5/31/19
Surveillance Markers for Recurrence After Neoadjuvant Chemotherapy for Breast Cancer	Laura Esserman, MD	Cancer/Oncology, Women's Health	6/1/14	5/31/19
Implementation of Tanzania’s Cancer Treatment Guidelines: A Qualitative Health Systems Approach	Rohan Luhar, BS	Cancer/Oncology, Systematic Reviews and Guideline Development	9/1/18	6/1/19
Quality Evaluation of Afghanistan’s Cancer Control Program	Homira Omar, BA	Cancer/Oncology, Systematic Reviews and Guideline Development	9/1/18	6/1/19
Evaluation of Colorectal Cancer Clinical Decision-Making and Outcomes at a National Cancer Referral Center in Dar es Salaam, Tanzania	Alex Keir, BS	Cancer/Oncology	9/1/18	6/1/19
Functional Manipulation of Memory Regulatory T cells in Skin		Cancer/Oncology, Immunology	9/30/14	6/30/19
MYCN, mTOR and translation control in medulloblastoma	William Weiss, MD, PhD	Cancer/Oncology, Pediatrics	9/1/14	6/30/19
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)	Norah Terrault, MD	Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease	8/1/14	6/30/19
Racial and Ethnic Disparities in Pediatric Leukemia	Lena Winestone, MD, MSHP	Cancer/Oncology, Pediatrics	7/1/18	6/30/19
Dissecting Translational Control of Cancer Progression		Cancer/Oncology	7/1/15	6/30/19
Inducible systems for studying liver tumor maintenance in vivo	Xin Chen, PhD	Cancer/Oncology, Genetics	7/1/17	6/30/19
Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia	Ophir Klein, MD, PhD	Cancer/Oncology	7/8/14	7/7/19
International Clinical Research Fellowship	Christopher Stewart, MD	Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training	2/1/17	7/31/19
Understanding the Interpersonal Context of HIV/HCV risk within Injecting Dyads	Meghan Morris, PhD, MPH	Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Cancer/Oncology	8/1/14	7/31/19
A Partnership for Training and Mentoring of Cancer Researchers in Tanzania	Katherine Van Loon Steitz, MD, MPH	Cancer/Oncology, Training and Capacity Building, Training International Scholars and Clinicians	8/1/18	7/31/19
SWI/SNF complex in mouse HCC development	Xin Chen, PhD	Cancer/Oncology, Genetics	8/1/17	7/31/19
Modeling the Impact of Targeted Therapy Based on Breast Cancer Subtypes	Laura Esserman, MD	Cancer/Oncology, Women's Health	9/18/14	8/31/19
Molecular and Cellular Mechanisms in Cancer	Zena Werb, PhD	Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training	9/9/14	8/31/19
Innovative Infrastructure to Enhance the California Teachers Study	Peggy J. Reynolds, PhD, MPH, MA	Cancer/Oncology, Occupational and Environmental Disease	5/1/18	8/31/19
Validation of the GeneXpert Breast Cancer STRAT4 Assay for Rapid Analysis of Breast Cancer Biomarker Status from Fine Needle Aspiration Biopsies in Tanzania (GX-BCB	Dianna Ng, MD	Cancer/Oncology, Drug and Diagnostics Development, Women's Health	6/13/18	8/31/19
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-associated Cancer	Jeffrey Martin, MD, MPH	HIV/AIDS, Opportunistic Infection, Cancer/Oncology	9/17/14	8/31/19
Planning for a Cancer Research Training Program in Tanzania	Katherine Van Loon Steitz, MD, MPH	Cancer/Oncology, Training International Scholars and Clinicians	9/19/18	8/31/19
Drugging the Switch-II Pocket of K-Ras	Kevan Shokat, PhD	Cancer/Oncology	9/12/14	8/31/19
Evaluating a community-driven cervical cancer prevention model in western Kenya	Megan Huchko, MD	HIV/AIDS, Cancer/Oncology, Women's Health	9/19/14	8/31/19
A study of environmental exposure to perfluorinated substances and cancer risk in California	Peggy J. Reynolds, PhD, MPH, MA	Cancer/Oncology, Occupational and Environmental Disease	9/17/18	9/16/19
CT DOSE Collaboratory	Rebecca Smith-Bindman, MD	Cancer/Oncology, Epidemiology and Surveillance, Risk Reduction and Prevention	9/12/14	12/31/19
A Phase 2, 2-Stage, 2-Cohort Study of BMN 673 Administered to Germline BRCA Mutation Subjects with Locally Advanced and/or Metastatic Breast Cancer.	Hope Rugo, MD	Cancer/Oncology	1/5/15	12/31/19
Developing an breast FNA biopsy service in Trujillo Peru	Ronald Balassanian, MD	Cancer/Oncology, Drug and Diagnostics Development, Women's Health	1/1/11	1/1/20
Integration of wound and lymphedema care within a population health model in Western Kenya	Aileen Y. Chang, MD	Cancer/Oncology, Training and Capacity Building	1/1/19	1/1/20
Phase II, Multicenter, Open-label Study to Assess the Efficacy and Safety of Enzalutumide with Trastuzumab in Subjects with Her2+ AR+ Metastatic or Locally Advanced Breast Cancer	Hope Rugo, MD	Cancer/Oncology, Women's Health	1/6/15	1/5/20
A Phase 1, Open-Label, Dose Escalation and Dose Expansion Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Orally Administered CB-5083 in Patients with Advanced Solid Tumors	Pamela Munster, MD	Cancer/Oncology	1/14/15	1/13/20
A Phase 3, Open-Label, Randomized, Parallel, 2-Arm, Multi-Center Study of BMN 673 versus Physician's Choice in Germline BRCA Mutation Subjects with Locally Advanced and/or Metastatic Breast Cancer, Who Have Received No More than 2 Prior Chemotherapy	Hope Rugo, MD	Cancer/Oncology, Pharmacology and Drug Treatment	11/25/14	1/16/20
A Technological Platform for the Identification of Serine Proteases in Cancer	Charles Craik, PhD	Cancer/Oncology, Drug and Diagnostics Development	8/1/15	1/31/20
Phase 2 Study of Ruxolitinib or Placebo in Combination with Capecitabine in Subjects with Advanced or Metastatic HER2-Negative Breast Cancer.	Hope Rugo, MD	Cancer/Oncology, Women's Health	2/10/15	2/10/20
Phase I Study to Evaluate the Tolerability, Safety and Efficacy of BMN-673 in Combination with Carboplatin and Paclitaxel in Patients with Advanced Solid Tumor Malignancies that have BRCA Mutations or Triple Negative Metastatic Breast Cancer	Pamela Munster, MD	Cancer/Oncology	2/13/15	2/12/20
Phase 1b/2 Study of MLN0128 (Dual TORC 1/2 Inhibitor) with Exemestane or Fulvestrant Therapy in Postmenopausal with ER+/HER2- Advanced or Metastatic Breast Cancer that has Progressed on Treatment With Everolimus in Combination With Exemestane or Fulvestra	Hope Rugo, MD	Cancer/Oncology, Women's Health	2/23/15	2/23/20
Using Stromal Markers to Improve Risk Stratification of Ductal Carcinoma in Situ	Thea Tlsty, PhD	Cancer/Oncology, Women's Health	4/1/15	3/31/20
Tension-Stat3-miR-mediated metastasis	Valerie Weaver, PhD	Cancer/Oncology, Women's Health	4/1/15	3/31/20
Targeting BET-bromodomains in neuroblastoma	William Weiss, MD, PhD	Cancer/Oncology, Drug and Diagnostics Development, Pediatrics	5/15/15	3/31/20
Colon Organoid Investigation of KRAS-Dependent Synthetic Lethality	Thomas McManus, PhD	Cancer/Oncology, Drug and Diagnostics Development	4/14/16	3/31/20
A Phase 2 Study of LY2835219 for Patients with Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer	Hope Rugo, MD	Cancer/Oncology, Women's Health	11/17/14	3/31/20
Long distance mentoring in global oncology	Anu Agrawal, MD	HIV/AIDS, Cancer/Oncology	1/1/15	4/1/20
A Phase 1A/1B, Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the Pleiotropic Pathway Modifier CC-122 Administered Orally to Subjects With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma	Pamela Munster, MD	Cancer/Oncology, Pharmacology and Drug Treatment	6/1/13	5/31/20
Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging	Rebecca Smith-Bindman, MD	Cancer/Oncology, Pediatrics, Adolescent Health, Epidemiology and Surveillance, Risk Reduction and Prevention	3/1/15	5/31/20
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Doxorubicin plus Olaratumab versus Doxorubicin plus Placebo in Patients with Advanced or Metastatic Soft Tissue Sarcoma		Cancer/Oncology, Pharmacology and Drug Treatment	12/9/15	6/12/20
Clinical Performance, Efficacy and Safety of the DigniCap System, a Scalp Hypothermia System, in Preventing Chemotherapy Induced Alopecia in Patients with Early Stage Breast Cancer	Hope Rugo, MD	Cancer/Oncology	6/28/15	6/28/20
CD36-dependent stromal signaling orchestrates acquisition of pro-tumorigenic phenotypes	Thea Tlsty, PhD	Cancer/Oncology, Women's Health	7/1/15	6/30/20
Cervical cancer screening among HIV positive Kenyan women	Erin Dainty, MD	Cancer/Oncology, Women's Health	7/1/14	6/30/20
A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel with or without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma		Cancer/Oncology, Drug and Diagnostics Development	6/6/16	6/30/20
Surgical and cancer screening capacity building	Loie Sauer, MD	Surgery and Anesthesia, Cancer/Oncology, Health Systems Strengthening, Training and Capacity Building	7/1/14	6/30/20
Role of GATA3 in transcriptional pathways suppressing breast cancer metastasis	Zena Werb, PhD	Cancer/Oncology, Women's Health	7/1/15	6/30/20
Menopausal Transition - A Window of Susceptibility for the Promotion of Breast Cancer by Environmental Exposures	Peggy J. Reynolds, PhD, MPH, MA	Cancer/Oncology, Occupational and Environmental Disease, Women's Health	5/1/18	6/30/20
Breast cancer risk assessment, screening and prevention	Jeffrey Tice, MD	Cancer/Oncology, Women's Health	7/1/14	6/30/20
Head and neck cancers in LMIC	Rahul Seth, MD	Surgery and Anesthesia, Cancer/Oncology	7/1/14	6/30/20
Pharmacogenomics of Microtubule Targeting Agents	Deanna Kroetz, PhD	Cancer/Oncology, Drug and Diagnostics Development	7/2/15	6/30/20
An Ethical Approach to Routine Tragic Choices: Radiotherapy Allocation in Rwanda	Rebecca J. Deboer, MD	Cancer/Oncology	7/1/18	6/30/20
International Society of Pediatric Oncology (SIOP) Pediatric Oncology in Developing Countries(PODC)	Linda Abramovitz, RN, MS	Cancer/Oncology	7/1/12	6/30/20
I-SPY 2 TRIAL (Investigation of Serial studies to Predict Your Therapeutic Response with Imaging And Molecular Analysis): An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy	Laura Esserman, MD	Cancer/Oncology	1/1/14	6/30/20
Immunotherapy of human bladder cancer	Lawrence Fong, MD	Cancer/Oncology	7/2/15	6/30/20
Twinning Black Lion Hospital in Addis Ababa, Ethiopia	Linda Abramovitz, RN, MS	Cancer/Oncology, Pediatrics, Training International Scholars and Clinicians	7/1/12	6/30/20
A Phase I, Dose Escalation Study To Establish Safety of Leukocyte Interleukin, Injection [Multikine] for Treatment of Perianal Condylomata In Adult Men and Women Who Are HIV/HPV Co-infected	Joel Palefsky, MD	HIV/AIDS, Opportunistic Infection, Cancer/Oncology	7/9/15	7/8/20
A Phase 1 Dose Escalation Study of OMP-52M51 in Subjects with Solid Tumors	Pamela Munster, MD	Cancer/Oncology	7/18/13	7/17/20
Clinical and biological characterization of Male Breast Cancer: an international EORTC, BIG, TBCRC and NABCG intergroup study- TBCRC 029	Hope Rugo, MD	Cancer/Oncology	9/25/15	7/31/20
Characterization of a novel role for Hippo-YAP pathway signaling in cancer progression and therapy resistance	Trever Bivona, MD, PhD	Cancer/Oncology	8/1/15	7/31/20
Pragmatic Trial of More Versus Less Intensive Strategies for Active Surveillance of Patients with Small Pulmonary Nodules	Rebecca Smith-Bindman, MD	Cancer/Oncology	8/1/15	7/31/20
A Technological Platform for the Identification of Serine Proteases in Cancer	Charles Craik, PhD	Cancer/Oncology, Drug and Diagnostics Development	9/30/15	7/31/20
Elimination of Instrumental Bias for Quantitative Diffusion Imaging in Clinical Oncology Trials	David Newitt, PhD	Cancer/Oncology, Drug and Diagnostics Development	8/10/15	7/31/20
A Phase 2 Proof-of-Concept Study of the Combination of ACP-196 and Pembrolizumab in Subjects with Advanced Non-small Cell Lung Carcinoma		Cancer/Oncology, Pharmacology and Drug Treatment	8/19/15	8/1/20
US and Canadian uranium processing cohorts: exposure, risk and relevance	Lydia Zablotska, MD, MPA, PhD	Cancer/Oncology, Occupational and Environmental Disease	9/1/18	8/31/20
Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#100135, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)"		Cancer/Oncology	9/11/15	8/31/20
Training Program in Translational Brain Tumor Research	Joseph Costello, PhD	Cancer/Oncology	9/1/15	8/31/20
AIDS Malignancy Consortium (AMC)	Lawrence Kaplan, MD	HIV/AIDS, Opportunistic Infection, Cancer/Oncology	9/1/15	8/31/20
UCSF / Northrop Grumman - Oncology Models Forum	Atul Butte, MD, PhD	Cancer/Oncology	9/1/15	8/31/20
Stigma as a barrier to cancer palliative care outcomes among people with HIV in India	Maria Ekstrand, PhD	Cancer/Oncology, Stigma and Discrimination	9/13/18	8/31/20
Phase 2, Parallel-Arm Study of MGCD265 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Activating Genetic Alterations in Mesenchymal-Epithelial Transition Factor		Cancer/Oncology, Genetics, Pharmacology and Drug Treatment	9/10/15	9/9/20
A Phase 1/2 Study of SL-701, a Subcutaneously Injected Multivalent Glioma-Associated Antigen Vaccine, in Adult Patients with Recurrent Glioblastoma Multiforme	Nicholas Butowski, MD	Cancer/Oncology	9/11/14	9/10/20
A Study of the Safety, Immunopharmacodymics and Anti-TumorActivity of Ibrutinib Combined with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma	Margaret Tempero, MD	Cancer/Oncology, Pharmacology and Drug Treatment	9/22/15	9/22/20
Living Tumor Biopsies to Interrogate Immune Function and Response to Therapy	Matthew Krummel, PhD	Cancer/Oncology	10/19/15	10/19/20
An Expanded Access Protocol of Oral Rociletinib (CO-1686) as Epidermal Growth Factor Receptor (EGFR)-Directed Therapy for Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) with the T790M Resistance Mutation		Cancer/Oncology, Pharmacology and Drug Treatment	10/28/15	10/27/20
An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients with Early-Stage HER2+ Breast Cancer Treated with Neratinib and Intensive Loperamide Prophylaxis.	Jo Chien, MD	Cancer/Oncology	11/5/15	11/4/20
ADXS31-142 in Combination with Pembrolizumab (MK-3475) in Patients with Previously Treated Metastatic Castration-Resistant Prostate Cancer	Lawrence Fong, MD	Cancer/Oncology, Pharmacology and Drug Treatment	11/9/15	11/8/20
A Phase 1 Open-Label, Dose-Finding Study Evaluating Safety and Pharmacokinetics of FPA144 in Patients with Advanced Solid Tumors		Cancer/Oncology, Pharmacology and Drug Treatment	11/19/15	11/18/20
A Phase 2 Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma (FLC)		Cancer/Oncology	12/3/15	12/3/20
Mount Zion Health Fund - Harold Dobbs Cancer Research Fund	Alan Venook, MD	Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training	12/7/15	12/7/20
CC 15957 A Phase 1, Open-Label Dose Escalation First-in-Human Study to Evaluate the Tolerability, Safety, Maximum Tolerated Dose, and Pharmacokinetics of AM0010 in Patients with Advanced Solid Tumors		Cancer/Oncology, Pharmacology and Drug Treatment	12/17/15	12/17/20
Molecular Basis for Transmembrane Conduction & Signaling	Robert Stroud, PhD	Cancer/Oncology, Immunology	3/15/17	12/31/20
A Phase 1/1b Study of MGCD516 in Patients with Advanced Solid Tumor Malignancies		Cancer/Oncology	1/7/16	1/7/21
Study of the Histone Deacetylase Inhibitor Romidepsin (Istodax®) in Combination with Doxorubicin HCl Liposomal (Doxil®) for the Treatment of Adults with Relapsed or Refractory Cutaneous T-cell Lymphoma	Ai Weiyun, MD, PhD	Cancer/Oncology	1/22/14	1/21/21
A Phase 2, Randomized, Open-Label, Multicenter, Safety and Efficacy Study of Oral Lucitanib in Patients with FGF Aberrant Metastatic Breast Cancer	Hope Rugo, MD	Cancer/Oncology, Women's Health	2/13/15	1/26/21
Occupational Chemical Exposures in California and Breast Cancer	Peggy J. Reynolds, PhD, MPH, MA	Cancer/Oncology, Occupational and Environmental Disease, Women's Health	5/1/18	1/31/21
Canadian Fluoroscopy Cohort Study: Lifespan Mortality and Incidence Follow-Up	Lydia Zablotska, MD, MPA, PhD	Cancer/Oncology, Occupational and Environmental Disease	2/1/16	1/31/21
Phase 1b Study of SAR650984 in Combo with Lenalidomide and Dexa for Treatment of Relapsed or Refractory Multiple Myeloma	Thomas Martin, MD	Cancer/Oncology, Drug and Diagnostics Development, Pharmacology and Drug Treatment	2/11/13	2/11/21
An Observational Cohort Study of Treatment Patterns and Outcomes in Patients with Her2 Positive (Her2+) Metastatic Breast Cancer	Hope Rugo, MD	Cancer/Oncology, Women's Health	3/11/13	3/11/21
Randomized, Double-Blind, Phase II Trial of Vitamin D Supplementation in Participants with Previously Untreated Metastatic Colorectal Cancer	Katherine Van Loon Steitz, MD, MPH	Cancer/Oncology, Drug and Diagnostics Development	3/28/13	3/28/21
Sleep and Cancer: Evaluation of Risk and Insights into Mechanisms	Peggy J. Reynolds, PhD, MPH, MA	Cancer/Oncology, Occupational and Environmental Disease	5/29/18	3/31/21
A Phase I/IIa Study of Safety and Efficacy of Alpharadin® with Docetaxel in Patients with Bone Metastases From Castration Resistant Prostate Cancer	Charles Ryan, MD	Cancer/Oncology, Pharmacology and Drug Treatment	4/25/13	4/25/21
A Phase 1b Open-label Study to Evaluate the Safety and Tolerability of MEDI4736 in Combination with Tremelimumab in Subjects with Advanced Non-small Cell Lung Cancer		Cancer/Oncology, Pharmacology and Drug Treatment	5/1/16	4/30/21
Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB054329 in Subjects With Advanced Malignancies	Pamela Munster, MD	Cancer/Oncology, Drug and Diagnostics Development	5/2/16	5/2/21
A Phase 1, Dose-Escalation/Dose-Expansion Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamic Effects of Orally Administered CB-5083 in Patients with Relapsed/Refractory Multiple Myeloma	Jeffrey Wolf, MD	Cancer/Oncology	8/26/14	5/25/21
The Patient Cancer OUtreach, Navigation, Technology and Support (COUNTS) Project: Addressing Care for Asian Americans with Cancer	Tung Nguyen, MD	Cancer/Oncology	6/1/18	5/31/21
Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions	Kathryn Phillips, PhD	Cancer/Oncology, Genetics	7/1/18	6/30/21
A Phase Ib Dose Escalation Trial of Carfilzomib plus Bendamustine and Rituximab in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma	Charalambos (Babis) Andreadis, MD	Cancer/Oncology, Drug and Diagnostics Development	7/7/14	7/6/21
A Randomized Phase IIB Open Label Study of Nivolumab or Nivolumab in Combination with Ipilimumab Versus Bevacizumab in Adult Subjects with Recurrent Glioblastoma (GBM)	Nicholas Butowski, MD	Cancer/Oncology	7/25/14	7/24/21
(PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years	Joel Palefsky, MD	Infectious Disease, HIV/AIDS, Cancer/Oncology	8/1/16	7/31/21
Phase II Single Agent Study of Selinexor (KPT-330) in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Prior Therapy with Abiraterone	Charles Ryan, MD	Cancer/Oncology	8/19/14	8/18/21
Biological implications of breast cancer protective variants in Latin American women with high Indigenous American ancestry	Laura Fejerman, PhD	Cancer/Oncology, Women's Health	9/1/16	8/31/21
Precision Targeting of Castration Resistant Prostate Cancer with a Novel Ferrous Iron-Dependent Therapeutic Delivery and Tumor Imaging Strategy	Adam Renslo, PhD	Cancer/Oncology, Immunology	9/30/18	9/29/21
CC# 159518 A Phase I, First-Time-in-Human Study of MEDI9197, a TLR 7/8 Agonist, Administered Intratumorally in Subjects with a Solid Tumor Cancer	Pamela Munster, MD	Cancer/Oncology, Drug and Diagnostics Development	1/23/16	11/23/21
Precision Genomics in the WISDOM Pragmatic Clinical Trial: An Embedded ELSI Study of Risk-based Breast Cancer Screening	Barbara Koenig, PhD	Cancer/Oncology, Genetics, Women's Health	1/12/17	12/31/21
Phase III Global Study of MEDI4736 in Combination with Tremelimumab Therapy or MEDI4736 Monotherapy vs Standard of Care Platinum-Based Chemotherapy in First-Line Treatment of Patients with Locally Advanced or Metastatic Non Small-Cell Lung Cancer		Cancer/Oncology, Pharmacology and Drug Treatment	12/30/15	12/31/21
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects with Glioblastoma Multiforme	Nicholas Butowski, MD	Cancer/Oncology, Neurology and Mental Health	3/2/15	2/19/22
Phase 1 Open Label, Multi-center Study to Assess the Safety, tolerability and Pharmacokinetics of Orally administered CUDC-907, an HDAC and PI3K Inhibitor in Subjects with Advanced/ Relapsed Solid Tumors	Pamela Munster, MD	Cancer/Oncology, Pharmacology and Drug Treatment	2/25/15	2/24/22
Anti-Tumor Mechanisms of Intratumoral Stimulatory Dendritic Cells	Matthew Krummel, PhD	Cancer/Oncology, Immunology	3/15/17	2/28/22
Radiomic phenotypes of breast parenchyma and breast cancer risk and detection	Karla Kerlikowske, MD	Cancer/Oncology, Women's Health	4/1/17	3/31/22
Developing silastic-silicone for the local delivery of hormonal therapy to prevent and treat breast cancer	Pamela Munster, MD	Cancer/Oncology, Drug and Diagnostics Development, Women's Health	7/1/17	5/31/22
CC# 16552 A Phase Ib, Open-Label Study Of The Safety And Tolerability Of Atezolizumab In Combination With Radium-223 Dichloride In Patients With Castrate-Resistant Prostate Cancer Who Have Progressed Following Treatment With An Androgen Pathway Inhib	Lawrence Fong, MD	Cancer/Oncology, Pharmacology and Drug Treatment	6/1/17	5/31/22
Improving Survivorship Care for Diverse Cancer Patients Cared for in Safety-net Settings	Urmimala Sarkar, MD	Cancer/Oncology, Implementation and Behavioral Science	7/1/17	6/30/22
University of California Global Health Institute Program for Fellows and Scholars	Craig Cohen, MD, MPH	Infectious Disease, HIV/AIDS, Tuberculosis, Malaria, Surgery and Anesthesia, Cancer/Oncology, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Pediatrics, Policy and Standards of Care, Epidemiology and Surveillance	7/1/17	6/30/22
Genetics of mammographic density and breast cancer risk in Latinas	Elad Ziv, MD	Cancer/Oncology, Women's Health	8/1/17	7/31/22
Multiple Myeloma Research Foundation Tissue Banking Agreement	Thomas Martin, MD	Cancer/Oncology	1/1/15	12/31/22
Plastic States Associated with Cellular Stress and Malignancy: Insights for Prevention and Treatment of Lethal Metaplastic Cancers	Thea Tlsty, PhD	Cancer/Oncology, Immunology	1/19/16	12/31/22
CC# 17872: Safety, Feasibility and Immunologic Correlatives of Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma	Jackie (Chia-Ching) Wang, MD	HIV/AIDS, Opportunistic Infection, Cancer/Oncology, Pharmacology and Drug Treatment	3/5/18	3/5/23
New Ways of Targeting K-Ras	Frank McCormick, PhD, FRS	Cancer/Oncology	4/1/16	3/31/23
Role of HIV in acceleration of HPV malignancy	Sharof Tugizov, PhD	HIV/AIDS, Sexually Transmitted Infections (STIs), Cancer/Oncology	12/1/18	11/30/23
Phase 1b Study To Assess The Safety, Tolerability, And Clinical Activity Of Gedatolisib In Combination With Palbociclib And Either Letrozole Or Fulvestrant In Women With Metastatic Or Locally Advanced/Recurrent Breast Cancer	Hope Rugo, MD	Cancer/Oncology	8/30/16	8/29/26

Active Projects: 388

Project	Investigator	All Topics	Start date	End date
Promotoras for Cancer Survivorship-Redes/LAF	Eliseo Perez-Stable, MD	Cancer/Oncology	6/1/80	5/31/81
The Breast and Cervical Cancer Care Coordination and Navigation Program	Claire Brindis, DrPH	Cancer/Oncology, Women's Health	3/1/04	12/31/04
Women and Infants Transmission Study - Human Papillomavirus Protocol	Joel Palefsky, MD	Infectious Disease, HIV/AIDS, Cancer/Oncology, Women's Health	7/1/03	6/30/05
HPV and AIDS Malignancies Clinical Trials Consortium (AMC)	Joel Palefsky, MD	HIV/AIDS, Cancer/Oncology	8/1/99	7/31/05
SMART Anal Dysplasia Sub-Study	Joel Palefsky, MD	HIV/AIDS, Opportunistic Infection, Cancer/Oncology	11/1/04	3/31/06
Redes En Accion: National Latino Cancer Research Network	Eliseo Perez-Stable, MD	Cancer/Oncology, Immigration and Migration, Engagement in Care	5/6/05	9/30/06
Exploring Early Detection Methods: Using the Intraductal Approach to Predict Breast Cancer	Kimberly Baltzell, RN, PhD, MS	Cancer/Oncology, Women's Health	5/15/03	12/14/06
Psychosocial Support Services for Latinas with Breast Cancer	Anna Napoles, PhD, MPH	Cancer/Oncology, Neurology and Mental Health, Women's Health	7/1/05	12/31/06
Active Surveillance for Early Stage Prostate Cancer: Selection, Monitoring	Peter Carroll, MD	Cancer/Oncology	5/5/06	4/30/07
Filipina Breast Cancer Support: Which Model is Meaningful? [2]	Nancy Burke, PhD	Cancer/Oncology	7/1/06	6/30/07
Herpesviral Gene Expression in Kaposi's Sarcoma	Donald E. Ganem, MD	HIV/AIDS, Cancer/Oncology, Genetics	9/1/01	8/31/07
Sinag Tala (Bright Star): Pilipina Breast Cancer Support Group Outreach	Nancy Burke, PhD	Cancer/Oncology	9/28/06	3/31/08
Mechanisms of Bartonella Virulence in AIDS Patients	Jane Koehler, MD	HIV/AIDS, Cancer/Oncology, Risk Reduction and Prevention	12/15/02	5/31/08
Anal Human Papillomavirus (HPV) in Methamphetamine (MA) Using and Non-Using Men Who Have Sex with Men (MSM) in Los Angeles	Joel Palefsky, MD	Infectious Disease, Cancer/Oncology, Substance Abuse, Risk Reduction and Prevention	7/1/04	6/30/08
California Division Special Research Scholar Grant in HIV-Related Cancers	Joel Palefsky, MD	HIV/AIDS, Cancer/Oncology	8/31/03	8/30/08
A Phase II Clinical Trial of Pembrolizumab as Monotherapy for Metastatic Triple-Negative Breast Cancer (mTNBC)	Hope Rugo, MD	Cancer/Oncology	9/1/04	8/31/08
HPV-Specific T Cell Responses and Anogenital HPV Disease in Women of the WIHS	Malcolm John, MD	HIV/AIDS, Cancer/Oncology, Women's Health	4/1/04	10/31/08
Test characteristics of nipple aspirate fluid cytology for the prediction of breast cancer	Jeffrey Tice, MD	Cancer/Oncology, Women's Health	10/8/08	4/7/09
Affinity Isolation of Direct Kinase Substrates	Kevan Shokat, PhD	Cancer/Oncology	5/15/03	4/30/09
Molecular Effects of Nutrition Supplements in Prostate	Peter Carroll, MD	Cancer/Oncology	6/10/03	5/31/09
Biochemistry and Hepatic Toxicity of Carbon Radicals	Paul Ortiz De Montellano, PhD	Cancer/Oncology	7/1/04	6/30/09
Doris Duke Charitable Foundation International Clinical Research Fellowship Program	Joel Palefsky, MD	HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Oral Health, Neurology and Mental Health, Women's Health, Pediatrics, Newborn and Infant Health, Immigration and Migration, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training	1/1/07	6/30/09
A Study Investigating the Association of HPV-Related Biomarkers with the Detection of Anal Precancer And Cancer in HIV-Positive Men Who Have Sex with Men (MSM)	Teresa Darragh, MD	HIV/AIDS, Cancer/Oncology	9/1/08	7/15/09
Merck Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi Sarcoma in Africa	Jeffrey Martin, MD, MPH	HIV/AIDS, Cancer/Oncology	12/19/06	7/31/09
Admixture Mapping for Breast Cancer Subtypes Among African American Women	Laura Fejerman, PhD	Cancer/Oncology, Women's Health	1/15/08	1/14/10
The Cancer Genome Atlas (TCGA) Pilot Program	Karen Smith-McCune, MD, PhD	Cancer/Oncology, Systematic Reviews and Guideline Development	8/1/07	1/31/10
Effects of the Chornobyl Accident on Thyroid Cancer and Leukemia & Related Diseases (NO1-CP-21178)	Lydia Zablotska, MD, MPA, PhD	Cancer/Oncology, Occupational and Environmental Disease	10/14/08	3/31/10
UCSF Prostate Cancer SPORE	Peter Carroll, MD	Cancer/Oncology	9/25/00	6/30/10
A Master Agreement: HPV Testing of Samples from the AIDS Malignancy Consortium	Joel Palefsky, MD	HIV/AIDS, Cancer/Oncology, Women's Health	9/1/06	7/31/10
UCSF-Kaiser Building Interdisciplinary Research Careers in Women's Health Program	Ruth Greenblatt, MD	HIV/AIDS, Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease, Diet, Exercise, and Obesity, Dementia and Cognitive Impairment, Women's Health, UCSF Professional Education	9/14/05	7/31/10
A Workshop on Applications of Mechanistic Information in Human Health Risk Assessment	Tracey Woodruff, PhD, MPH	Cancer/Oncology, Occupational and Environmental Disease	5/1/08	7/31/10
Cidofovir for Perianal Dysplasia in HIV Patients	Joel Palefsky, MD	HIV/AIDS, Cancer/Oncology	9/1/07	8/31/10
Immunosenescence Profiles of Atypical Cases of Kaposi Sarcoma in Well-Controlled HIV Infection	Toby Maurer, MD	HIV/AIDS, Cancer/Oncology	7/1/07	12/31/10
Biomarkers that Predict the Response of AIDS-Related Kaposi's Sarcoma to Antiretroviral Therapy and the Risk of Developing Immune Reconstitution Inflammatory Syndrome		HIV/AIDS, Cancer/Oncology	7/1/10	6/1/11
Immunoprotective Effects of Lopinavir/Ritonavir in HIV-Infected Patients in Sub-Saharan Africa	Jeffrey Martin, MD, MPH	HIV/AIDS, Cancer/Oncology	12/10/07	6/30/11
Viruses in Breast Fluid: Biomarkers for Breast Cancer?	Kimberly Baltzell, RN, PhD, MS	Cancer/Oncology, Drug and Diagnostics Development, Women's Health	1/1/08	6/30/11
Communicating about Clinical Trials: Bringing the Cancer Information Service (CIS) to the Underserved [II]	Nancy Burke, PhD	Cancer/Oncology, Patient and Peer Education	7/1/09	6/30/11
Bay Area Breast Cancer and Environment Research Center	Robert Hiatt, MD, PhD	Cancer/Oncology, Women's Health	9/3/09	8/31/11
Filipina Breast Cancer Support: What Model is Meaningful? [1]	Nancy Burke, PhD	Cancer/Oncology	11/1/07	11/1/11
Texas Children’s Hospital Global Health Service Corps	Anu Agrawal, MD	Cancer/Oncology, Pediatrics	1/1/11	1/1/12
Pediatric Kaposi Sarcoma, Botswana 2012 HIV Clinical Management Guidelines	Anu Agrawal, MD	HIV/AIDS, Cancer/Oncology, Pediatrics	1/1/12	6/30/12
Bay Area Breast Cancer and the Environment Research Center	Robert Hiatt, MD, PhD	Cancer/Oncology, Occupational and Environmental Disease	9/29/03	7/31/12
Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa	Jeffrey Martin, MD, MPH	HIV/AIDS, Cancer/Oncology	9/30/05	7/31/12
NAAccord (CHK-UP on HIV Supplement)	Jeffrey Martin, MD, MPH	HIV/AIDS, Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease	9/22/09	8/31/12
To Discover and Characterize Novel Viruses in Cancer	Charles Chiu, MD, PhD	Infectious Disease, Cancer/Oncology	3/1/10	8/31/12
Determinants of Participation in an Anal Cancer Prevention Trial	Joel Palefsky, MD	Cancer/Oncology	9/30/09	8/31/12
Partnership to Advance Breast Cancer Research	Tracey Woodruff, PhD, MPH	Cancer/Oncology, Occupational and Environmental Disease, Women's Health	9/24/10	9/23/12
Phase II Study of 7 Days On/7 Days Off Temozolomide in Patients with High Grade Glioma	Nicholas Butowski, MD	Cancer/Oncology, Pharmacology and Drug Treatment	10/9/07	10/9/12
Abbott Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa	Jeffrey Martin, MD, MPH	HIV/AIDS, Cancer/Oncology	4/3/07	11/12/12
Probe Development for Prostate Cancer	Henry Vanbrocklin, PhD	Cancer/Oncology	2/1/11	3/1/13
Clinical Trials Education and Access for Underserved Women	Galen Joseph, PhD	Cancer/Oncology, Patient and Peer Education	8/1/11	4/30/13
Noninvasive Identifiers of Women with High Breast Density	John Shepherd, PhD	Cancer/Oncology, Women's Health	8/1/12	5/31/13
Nuevo Amanecer: Promoting the Psychosocial Health of Latinas	Anna Napoles, PhD, MPH	Cancer/Oncology, Neurology and Mental Health, Women's Health	7/1/09	6/30/13
Taste for the Cure and a Taste of Science	Laura Esserman, MD	Cancer/Oncology, Women's Health	7/1/12	6/30/13
Paternal Smoking and DNA Methylation in Childhood Leukemia	Joseph Wiemels, PhD	Cancer/Oncology, Pediatrics, Smoking and Tobacco	7/1/09	6/30/13
Epidemiologic Effects of ART on HIV-related Anal Cancer and Anal Dysplasia	Joel Palefsky, MD	Infectious Disease, HIV/AIDS, Cancer/Oncology	7/1/07	6/30/13
Athena Breast Care Network	Laura Esserman, MD	Cancer/Oncology, Women's Health	1/1/10	6/30/13
Cervical Cancer Screening with a Novel Biomarker in HIV-Infected Women	Megan Huchko, MD	HIV/AIDS, Cancer/Oncology	7/1/11	6/30/13
New treatments for triple negative breast cancer through the biparatopic inhibition of the uPAR receptor		Cancer/Oncology	7/1/13	7/2/13
6th International Workshop on Breast Cancer Risk Assessment	John Shepherd, PhD	Cancer/Oncology, Women's Health	1/15/13	7/7/13
Pharmacogenetics of Chemotherapy-Induced Toxicity in Breast Cancer	Deanna Kroetz, PhD	Cancer/Oncology, Genetics, Pharmacology and Drug Treatment, Women's Health	8/1/12	7/31/13
Alex's Lemonade Stand Foundation Post Program	Katherine Matthay, MD	Cancer/Oncology, Pediatrics	6/17/13	8/23/13
Development of Targeted Anti-Cancer Platinum Analogs	Kathleen Giacomini, PhD	Cancer/Oncology, Drug and Diagnostics Development	9/1/12	8/31/13
St. Baldrick's Summer Fellowship	Michelle Hermiston, MD, PhD	Cancer/Oncology, Pediatrics, Risk Reduction and Prevention	6/1/13	8/31/13
Open-Label, Expanded Access Protocol of BSI-201 in Combination with Gemcitabine/Carboplatin in Patients with ER-, PR-, and HER2-Negative Metastatic Breast Cancer	Hope Rugo, MD	Cancer/Oncology, Women's Health	8/26/10	8/31/13
Early Detection of Metastasis-Prone Breast Cancers	Laura Esserman, MD	Cancer/Oncology, Drug and Diagnostics Development, Women's Health	6/20/08	9/16/13
Role of Metalloproteinases in Mammary Gland Remodeling	Zena Werb, PhD	Cancer/Oncology	8/1/08	9/29/13
Children's Oncology Group Acute Lymphoblastic Leukemia High Risk Molecular Markers	Mignon Loh, MD	Cancer/Oncology	4/1/12	9/30/13
Adult Brain Tumor Consortium (ABTC)	Michael Prados, MD	Cancer/Oncology	1/1/09	12/31/13
Adjuvant Treatment with Temodar plus Avastin Alone or with Tarceva in Patient with Newly Diagnosed Glioblastoma Multiforme Who Are Stable Following Radiotherapy with Temodar	Michael Prados, MD	Cancer/Oncology, Pharmacology and Drug Treatment	8/15/07	12/31/13
Buong Puso: Linking Filipinas with Breast Cancer to Care and Support Resources	Nancy Burke, PhD	Cancer/Oncology	1/1/13	12/31/13
Genome-Wide Predictors of Treatment-Related Toxicities	Deanna Kroetz, PhD	Cancer/Oncology, Women's Health	1/19/11	12/31/13
Colorectal Cancer Screening with FIT during Annual Flu Shot Clinics	Michael Potter, MD	Cancer/Oncology, Engagement in Care, Patient and Peer Education	1/1/09	12/31/13
Sanofi-Aventis SAR650894 Program - Clinical Component	Thomas Martin, MD	Cancer/Oncology, Drug and Diagnostics Development	12/9/12	12/31/13
Prevention and Treatment of Impotence	Tom Lue, MD	Cancer/Oncology, Risk Reduction and Prevention	1/1/09	12/31/13
Sanofi-Aventis SAR650894 Program - Research Component	Thomas Martin, MD	Cancer/Oncology, Drug and Diagnostics Development	12/9/12	12/31/13
Cellular and Genetic Origins of Astrocytes	David Rowitch, MD, PhD	Noncommunicable and/or Chronic Disease, Cancer/Oncology, Neurology and Mental Health, Risk Reduction and Prevention	2/1/08	1/31/14
Reducing Disparities in Colorectal Cancer Screening in Vietnamese Americans	Tung Nguyen, MD	Cancer/Oncology	3/12/08	1/31/14
Pre-B Cell Receptor Signaling in Acute Lymphoblastic Leukemia	Markus Muschen, MD, PhD	Cancer/Oncology	2/1/13	1/31/14
Breast Cancer Risk Reduction in Primary Care Clinics: A Bilingual Intervention for Women and Physicians	Celia Kaplan, DrPH	Cancer/Oncology, Women's Health	2/3/10	2/2/14
Individually Optimized Conditioning Using PK-directed Dose Adjustment of Once Daily IV Busulfan, Followed by Autologous Hematopoietic Stem Cell Transplant	Ai Weiyun, MD, PhD	Cancer/Oncology, Pharmacology and Drug Treatment	2/18/11	2/17/14
Metabolic Imaging of the Prostate Using 3-D MRSI	Daniel Vigneron, PhD	Cancer/Oncology, Risk Reduction and Prevention	4/1/07	2/28/14
HIV and HPV Transmission Across Mucosal Epithelia	Sharof Tugizov, PhD	HIV/AIDS, Cancer/Oncology	5/1/13	2/28/14
The Kit Signaling Pathway As a Therapeutic Target in Melanoma	Boris Bastian, MD, PhD	Cancer/Oncology	10/1/08	3/1/14
Kaposi Sarcoma Subgroup of WHO Guidelines Development Group for HIV-Associated Skin and Oral Conditions	Anu Agrawal, MD	HIV/AIDS, Cancer/Oncology, Pediatrics	10/1/13	4/1/14
Genetic Analysis of the Nucleosome and RNA Polymerase II: a Systems Approach	Nevan Krogan, PhD, MSc	Noncommunicable and/or Chronic Disease, Cancer/Oncology, Genetics	1/3/08	4/30/14
Transcriptional Regulation of Breast Cancer Metastasis	Zena Werb, PhD	Cancer/Oncology, Women's Health	7/1/08	4/30/14
Research and Evaluation of the Virtual Symposium on Radiation Safety in Computed Tomography (CT)	Rebecca Smith-Bindman, MD	Cancer/Oncology, Epidemiology and Surveillance, Risk Reduction and Prevention	5/8/13	5/7/14
Anal Cytology/HPV Testing Study	Joel Palefsky, MD	Infectious Disease, Cancer/Oncology, Systematic Reviews and Guideline Development	10/1/12	5/16/14
Admixture Mapping for Breast Cancer in Latinas	Elad Ziv, MD	Cancer/Oncology, Women's Health	8/7/07	5/31/14
Promotoras for Cancer Survivorship-Redes/LAF	Eliseo Perez-Stable, MD	Cancer/Oncology, Women's Health	6/1/11	5/31/14
The Role of Microenvironment-Mediated CXCR4/CXCL12 Axis in Inducing Chemoresistance in Pediatric T-Cell Acute Lymphoblastic Leukemia	Michelle Hermiston, MD, PhD	Cancer/Oncology, Pediatrics	9/2/13	5/31/14
Phase I Parallel Protocol of MK-8669 (Ridaforolimus) + MK-2206 and MK-8669 (Ridaforolimus) + MK-0752 Doublets (MKMK) in Patients with Advanced Cancer	Pamela Munster, MD	Cancer/Oncology	2/25/11	6/14/14
Prostate Cancer and Pesticides	Paul Mills, PhD	Cancer/Oncology, Occupational and Environmental Disease	7/1/09	6/30/14
Targeting the translational apparatus in MYCN-driven medulloblastoma	William Weiss, MD, PhD	Cancer/Oncology	7/1/13	6/30/14
A Phase I Study to Assess the Bioequivalence of 2 Formulations of TKI258, FMI Capsule and FMI Tablet, in Patients with Advanced Solid Tumors	Pamela Munster, MD	Cancer/Oncology	9/5/11	6/30/14
Communicating about Clinical Trials: Bringing the Cancer Information Service (CIS) to the Underserved [I]	Nancy Burke, PhD	Cancer/Oncology	7/1/08	6/30/14
Nuevo Amanecer: Promoting the Psychosocial Health of Latinas	Anna Napoles, PhD, MPH	Cancer/Oncology, Women's Health	4/1/13	6/30/14
Hemoprotein Oxidation and Heme Catabolism	Paul Ortiz De Montellano, PhD	Cancer/Oncology	7/1/10	6/30/14
Quality of Mammography Facilities Serving Vulnerable Women		Cancer/Oncology, Women's Health	5/1/13	6/30/14
Phase 1b, Open-Label, Dose-Escalation Study of the Safety and Pharmacology of MEGF0444A, A Humanized 1gG1 Antibody in Combination with Bevacizumab with or without Paclitaxel in Patients with Locally Advanced or Metastatic Solid Tumors	Pamela Munster, MD	Cancer/Oncology, Pharmacology and Drug Treatment	5/26/10	6/30/14
Biomarkers for Environmental Exposures in Breast Cancer	Zena Werb, PhD	Cancer/Oncology, Women's Health	7/1/11	6/30/14
New Approaches to Neuroblastoma Therapy (NANT)	Katherine Matthay, MD	Cancer/Oncology, Neurology and Mental Health	7/1/11	6/30/14
Compassionate Use of Marqibo for the Treatment of Refractory Lymphoblastic Leukemia/Leukemia	Charalambos (Babis) Andreadis, MD	Cancer/Oncology, Pharmacology and Drug Treatment	7/7/13	7/1/14
New Paradigm of Breast Cancer Causation and Prevention	Robert Hiatt, MD, PhD	Cancer/Oncology, Occupational and Environmental Disease	3/1/09	7/31/14
New Paradigm of Breast Cancer Causation & Prevention	Robert Hiatt, MD, PhD	Cancer/Oncology, Women's Health	2/19/14	7/31/14
Fundamental Mechanobiology of Tumor Progression	Frank McCormick, PhD, FRS	Cancer/Oncology	9/29/09	7/31/14
Fundamental Mechanobiology of Tumor Progression	Frank McCormick, PhD, FRS	Cancer/Oncology	8/1/13	7/31/14
New Paradigm of Breast Cancer Causation and Prevention	Robert Hiatt, MD, PhD	Cancer/Oncology, Women's Health	5/1/12	7/31/14
Functional Studies on Genetic Variants of PTPN14	Rosemary Akhurst, PhD	Cancer/Oncology	8/16/13	8/15/14
Molecular and Cellular Mechanisms in Cancer	Zena Werb, PhD	Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training	9/1/09	8/31/14
Development of Transporter Targeted Platinum Drugs for Neuroblastoma	Kathleen Giacomini, PhD	Cancer/Oncology, Neurology and Mental Health	7/2/13	8/31/14
Leveraging the California Cancer Registry to Measure and Improve the Quality of Cancer Care	Robert Hiatt, MD, PhD	Cancer/Oncology, Health Economics and Effectiveness, Epidemiology and Surveillance	7/1/13	9/30/14
Deciphering Cellular Heterogeneity of the Normal Breast to Understand the Origin of Ductal Cancer In Situ (DCIS)	Laura Esserman, MD	Cancer/Oncology, Women's Health	10/1/13	9/30/14
Study of AMG 479 with Exemestane or Fulvestrant in Postmenopausal Women with Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer	Michelle Melisko, MD	Cancer/Oncology, Women's Health	8/25/08	10/31/14
Mount Zion Health Fund Transdisciplinary Team Award	Eric Small, MD	Cancer/Oncology	8/1/13	10/31/14
Structuring population health sciences within a faculty of health sciences in East Africa	Robert Hiatt, MD, PhD	Cancer/Oncology, Health Systems Strengthening, Training and Capacity Building	7/1/14	12/31/14
A Phase I Open-Label, Dose-Escalation Study of the Phosphoinositide 3-Kinase Inhibitor GSK2126458 in Subjects with Solid Tumors or Lymphoma	Pamela Munster, MD	Cancer/Oncology	9/21/09	12/31/14
TCGA (Cancer Genome Atlas)	Michael Prados, MD	Cancer/Oncology	3/26/13	12/31/14
BEACON Study (BrEAst Cancer Outcomes with NKTR-102): Phase 3 Study of NKTR-102 versus Treatment of Physician's Choice (TPC) in Patients with Locally Recurrent or Metastatic Breast Cancer Previously Treated with Anthracycline, a Taxane and Capecitabine	Hope Rugo, MD	Cancer/Oncology, Pharmacology and Drug Treatment, Women's Health	3/6/13	12/31/14
Breast Cancer Risk Reduction: A Patient-Doctor Intervention	Celia Kaplan, DrPH	Cancer/Oncology, Women's Health	4/1/13	12/31/14
Environmental and Molecular Epidemiology of Childhood Leukemia	Mignon Loh, MD	Cancer/Oncology, Pediatrics	8/1/10	1/31/15
AID-Mediated Genetic Instability in Bcr-Abl1-Transformed B Cell Lineage Leukemia	Markus Muschen, MD, PhD	Cancer/Oncology	2/1/13	1/31/15
Molecular Genetics of Liver Cancers	Xin Chen, PhD	Cancer/Oncology, Genetics	5/1/09	2/28/15
Subregional Breast Density and Cancer Risk	John Shepherd, PhD	Cancer/Oncology	3/1/12	2/28/15
Parsing Out The Role Of PI3'-Kinase Signaling In Lung Cancer Initiation, Progression And Therapy	Martin McMahon, PhD	Cancer/Oncology	3/1/13	2/28/15
Lipogenic Inhibitors in Prevention of Oncogene Induced Liver Cancer	Xin Chen, PhD	Cancer/Oncology	3/1/12	2/28/15
DAIDS A5298 Study: A Randomized, Double-Blinded, Placebo-Controlled, Phase III Trial of the Quadrivalent HPV Vaccine to Prevent Anal Human Papillomavirus Infection in HIV-Infected Men	Anne Luetkemeyer, MD	HIV/AIDS, Cancer/Oncology	3/22/12	3/21/15
HPV & Cervix Neoplasia in a Large, Long Term HIV+ Cohort	Teresa Darragh, MD	Sexually Transmitted Infections (STIs), HIV/AIDS, Cancer/Oncology	5/1/10	4/30/15
HPV Cervical Neoplasia in a Long-Term HIV+ Cohort	Joel Palefsky, MD	Sexually Transmitted Infections (STIs), Cancer/Oncology, Women's Health	5/19/05	4/30/15
A Phase 1B, Multi-Center, Open Label, Dose Escalation Study of Oral LDE225 in Combination with BKM120 in Patients with Advanced Solid Tumors	Pamela Munster, MD	Cancer/Oncology, Women's Health	11/1/12	4/30/15
Regulation of Genomic Instability in Early Breast Cancer	Thea Tlsty, PhD	Cancer/Oncology, Immunology	6/8/09	4/30/15
A Pilot Study of FOLFOX in Combination with Bevacizumab in Patients with Advanced Neuroendocrine Tumors	Emily Bergsland, MD	Cancer/Oncology, Pharmacology and Drug Treatment	5/12/05	5/11/15
Phase 1 Open-Label First-in-Human Dose-Escalating Safety and Tolerability Study Evaluating Subcutaneous Administration of Andes-1537 for Injection in Patients With Advanced Unresectable Malignancies That Are Refractory to All Standard	Pamela Munster, MD	Cancer/Oncology, Pharmacology and Drug Treatment	12/15/14	6/14/15
Cell Competition in the Developing Mouse Germline	Diana Laird, PhD	Cancer/Oncology, Family Planning, Pediatrics, Newborn and Infant Health	9/30/10	6/30/15
Oncogenic Viral Biomarkers in Nonmalignant Human Breast Tissue	Kimberly Baltzell, RN, PhD, MS	Cancer/Oncology, Drug and Diagnostics Development, Women's Health	1/1/12	6/30/15
CIBMTR Protocol 09-MRD	Christopher Dvorak, MD	Cancer/Oncology, Pediatrics	7/1/12	6/30/15
PAAR4Kids-Pharmacogenomics Research Network	Mignon Loh, MD	Cancer/Oncology, Genetics, Pharmacology and Drug Treatment	7/15/10	6/30/15
Phase 1 Study of IMC-CS4, a Monoclonal Antibody Targeted to the CSF-1 Receptor (CSF-1R), in Subjects With Advanced Solid Tumors Refractory to Standard Therapy or for Which No Standard Therapy is Available	Hope Rugo, MD	Cancer/Oncology	7/1/11	6/30/15
Creating a Model Integrative Medicine Program for Head and Neck Cancer at the Osher Center		Cancer/Oncology	7/1/13	6/30/15
Protocol GS-US-334-0139 An Expanded Access Phase 2 Study of Sofosbuvir and Ribavarin with or without Pegylated Interferon for 24 Weeks in Subjects Who Have Undergone Liver Transplantation and Who Have Aggressive Recurrent Hepatitis C Infection	Kathleen Tebb, PhD	Infectious Disease, Cancer/Oncology	4/8/13	6/30/15
Mount Zion Health Fund Scholars Program for Recruitment /Retention of Promising Clinical /Translational Investigators	Eric Small, MD	Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training	7/1/13	6/30/15
Fusion Genes As Therapeutic Targets in Malignant Pleural Mesothelioma	Il Jin Kim, PhD	Cancer/Oncology, Drug and Diagnostics Development	1/1/13	6/30/15
A Phase Ib Dose Escalation/Randomized Phase II, Multicenter, Open-label Study of BYL719 in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma	Pamela Munster, MD	Cancer/Oncology	2/1/13	7/1/15
Using Epigenetic Changes to Stratify DCIS Biopsies	Thea Tlsty, PhD	Cancer/Oncology, Women's Health	8/1/12	7/31/15
Predicting Early and Late Recurrence to Improve Care	Laura Esserman, MD	Cancer/Oncology, Women's Health	8/1/12	7/31/15
Environmental and Molecular Epidemiology of Childhood Leukemia	Joseph Wiemels, PhD	Cancer/Oncology	8/1/10	7/31/15
Environmental effects of the mammary gland across the lifespan	Zena Werb, PhD	Cancer/Oncology, Occupational and Environmental Disease, Women's Health	9/1/10	7/31/15
Explosive Evolution Under Stress: the Driving Forces of Cancer Dynamics - Project 2	Thea Tlsty, PhD	Cancer/Oncology	9/28/09	7/31/15
Explosive Evolution Under Stress: the Driving Forces of Cancer Dynamics - Project 1	Thea Tlsty, PhD	Cancer/Oncology	9/28/09	7/31/15
Using Epigenetic Changes to Stratify DCIS Biopsies	Thea Tlsty, PhD	Cancer/Oncology, Women's Health	5/1/13	7/31/15
Center for Interdisciplinary Research on Childhood Leukemia and the Environment	John Balmes, MD	Cancer/Oncology, Occupational and Environmental Disease, Pediatrics	8/1/10	7/31/15
Risk of Leukemia after Protracted Exposures to Low Doses of Ionizing Radiation.	Lydia Zablotska, MD, MPA, PhD	Noncommunicable and/or Chronic Disease, Cancer/Oncology, Genetics, Epidemiology and Surveillance, Risk Reduction and Prevention	4/1/10	7/31/15
Lay health workers and colorectal cancer screening among Chinese Americans	Tung Nguyen, MD	Cancer/Oncology, Patient and Peer Education	9/1/09	7/31/15
Spirit of Eagles Communities Network Program	Neal Benowitz, MD	Cancer/Oncology	9/20/10	8/31/15
Non-Invasive Assessment of Bone Micro-Architecture and Strength Changes in Androgen Deprivation Therapy in Prostate Cancer As a Model for Male Secondary Osteoporosis	Sharmila Majumdar, PhD	Cancer/Oncology	5/9/11	8/31/15
Uganda-UCSF Research Training Program in HIV-Associated Malignancies	Jeffrey Martin, MD, MPH	HIV/AIDS, Cancer/Oncology	9/9/10	8/31/15
Training Program in Translational Brain Tumor Research	Russell Pieper, PhD	Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training	9/1/10	8/31/15
Role of Fibroblasts, Myeloid Cells and Matrix in Pancreatic Ductal Adenocarcinoma (PDAC)	Valerie Weaver, PhD	Cancer/Oncology	9/1/12	8/31/15
Redes En Acción: National Latino Cancer Research Network	Eliseo Perez-Stable, MD	Cancer/Oncology	9/3/10	8/31/15
Regulation of Mammary Epithelial Signaling by Local Matrix Stiffness	Thea Tlsty, PhD	Cancer/Oncology, Women's Health	9/1/12	8/31/15
AIDS Malignancies Consortium	Lawrence Kaplan, MD	HIV/AIDS, Cancer/Oncology	9/1/10	8/31/15
HPV-Related Neoplasia among HIV-Seropositive Indian Men Who Have Sex With Men	Joel Palefsky, MD	HIV/AIDS, Cancer/Oncology	9/21/11	8/31/15
MiRNAs as prognostic markers for prostate cancer patients on active surveillance	Robert Blelloch, MD, PhD	Cancer/Oncology, Drug and Diagnostics Development	9/1/11	8/31/15
A comparison of the preferences among HIV+ and low risk women towards Cervical Cancer Screening and Prevention using health utilities: A Quantitative Study	Keerthana Anand, MS	HIV/AIDS, Cancer/Oncology, Women's Health	9/1/14	9/1/15
Human papillomavirus and the impact of needle-free vaccination on incidence in Thai women: a quantitative study	Sneh Patel, MS	Infectious Disease, Cancer/Oncology, Pediatrics	9/1/14	9/1/15
Imaging Oncogene Activation and Tumor Development in Genetically Engineered Mice	Martin McMahon, PhD	Cancer/Oncology	11/15/11	9/19/15
Prenatal Exposures, DNA Methylation & Childhood Leukemia	Joseph Wiemels, PhD	Cancer/Oncology, Pediatrics	9/25/10	9/24/15
A Study of Etiology of Esophageal Cancer in Tanzania (SEEC-Tanzania)	Peter Carroll, MD	Cancer/Oncology	4/1/14	9/25/15
Radiation Oncology Solutions in Tanzania	Owen Kenton, MS	Cancer/Oncology	10/16/14	10/16/15
Immune and Collagen Basis of Breast Cancer	Valerie Weaver, PhD	Cancer/Oncology, Women's Health	11/30/11	11/29/15
Embryonic signaling pathways in pancreatic cancer	Matthias Hebrok, PhD	Cancer/Oncology	12/1/09	11/30/15
The GNAQ pathway as a therapeutic target in uveal melanoma	Boris Bastian, MD, PhD	Cancer/Oncology	4/20/12	11/30/15
GINI: Gardasil Immunogenicity with Needle-free Injection-Safety and Immunogenicity of Gardasil using IM and ID needle-free injection delivery	Joel Palefsky, MD	Sexually Transmitted Infections (STIs), Cancer/Oncology	12/2/13	12/1/15
Targeting Adaptive Pathways in Resistant CRPC	Eric Small, MD	Cancer/Oncology	1/1/13	12/31/15
Clinical Investigator Research Program for Pilot Research Studies 2014	Eric Small, MD	Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training	7/1/14	12/31/15
Partnership to Advance Breast Cancer Research	Tracey Woodruff, PhD, MPH	Cancer/Oncology, Women's Health	9/24/12	12/31/15
Phase IA, Multicenter, Open-label Dose Escalation Study of Oral BYL719, in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene	Hope Rugo, MD	Cancer/Oncology	3/12/13	12/31/15
Support for a Multiple Myeloma Project Coordinator	Jeffrey Wolf, MD	Cancer/Oncology	1/1/10	12/31/15
International Case-Control Study of Malignant Glioma	Margaret Wrensch, PhD	Cancer/Oncology	9/1/11	12/31/15
JBAL: A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate plus Lomustine Therapy compared to Lomustine Monotherapy in Patients with Recurrent Glioblastoma	Nicholas Butowski, MD	Cancer/Oncology, Pharmacology and Drug Treatment	6/12/12	12/31/15
Risk-Benefit Trade-Offs for Whole Genome Sequencing	Kathryn Phillips, PhD	Cancer/Oncology, Genetics	2/15/13	1/31/16
Phase I Study of INC280 plus Erlotinib in Patients With C-Met Expressing Non-Small Cell Lung Cancer.		Cancer/Oncology	8/28/15	1/31/16
Thai Red Cross S&S, HN177	Joel Palefsky, MD	Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology	3/11/15	1/31/16
A Multicenter Phase I/II Trial of Abiraterone + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer	Charles Ryan, MD	Cancer/Oncology	2/1/13	2/1/16
Lung Cancer Screening: The Views of Patients and Physicians	Celia Kaplan, DrPH	Cancer/Oncology, Chronic Respiratory Disease	8/18/15	2/18/16
A phase I/II, multicenter, open-label dose finding study of oral CFG920 in patients with metastatic castration-resistant prostate cancer	Charles Ryan, MD	Cancer/Oncology	8/26/13	2/28/16
Pathogenesis of HIV-Related Bacillary Angiomatosis	Jane Koehler, MD	HIV/AIDS, Opportunistic Infection, Infectious Disease, Cancer/Oncology	3/1/13	2/29/16
Meeting the self-care needs of Latinas after Breast Cancer	Anna Napoles, PhD, MPH	Cancer/Oncology, Women's Health, Access or Barriers to Care, Immigration and Migration	9/1/13	2/29/16
TGF-ß Suppression and Promotion of Mammary Carcinomas	Valerie Weaver, PhD	Cancer/Oncology, Women's Health	3/4/11	2/29/16
UCSF Cutaneous Immunology Core: OSM Project		Opportunistic Infection, Cancer/Oncology, Immunology	3/1/13	3/12/16
Enabling New Translational Discoveries Using a Genomic Data-Driven Nosology	Atul Butte, MD, PhD	Cancer/Oncology, Immunology	4/1/15	3/31/16
Extracellular Proteolysis as a Molecular Stratification Tool for Cancer	Charles Craik, PhD	Cancer/Oncology	7/1/15	3/31/16
Cellular and Genetic Basis of Anaplastic Medulloblastoma	William Weiss, MD, PhD	Cancer/Oncology, Pediatrics	4/4/11	3/31/16
Infectious Origins of Childhood Leukemia [II]	Markus Muschen, MD, PhD	Cancer/Oncology	2/1/13	3/31/16
Impact of molecular phenotype on glioma metabolism and growth	Sarah Nelson, PhD	Cancer/Oncology	4/1/11	3/31/16
A Phase I Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan Using Imaging in High Grade Glioma	Nicholas Butowski, MD	Cancer/Oncology	4/1/14	3/31/16
Patient Centered Videos to Enhance Informed Consent for Palliative Chemotherapy	Katherine Van Loon Steitz, MD, MPH	Cancer/Oncology	4/1/15	3/31/16
Project 2: Human Melanoma -- Etiology, Progression, and Therapy	Boris Bastian, MD, PhD	Cancer/Oncology	4/1/12	3/31/16
Translating a Stress Management Program for Latinas	Anna Napoles, PhD, MPH	Cancer/Oncology, Women's Health, Access or Barriers to Care	4/3/15	4/2/16
Beacon (Breast Cancer Outcomes with Nktr-102): a Phase 3 Study of Nktr-102 Versus Treatment of Physician's Choice in Patients with Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline, Taxane and Capecitabine	Hope Rugo, MD	Cancer/Oncology, Women's Health	4/25/12	4/25/16
A Phase II, Single Arm Study of the Use of Steroid-Based Mouthwash to Prevent Stomatitis in Postmenopausal Women with Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated with Everolimus plus Exemestane.	Hope Rugo, MD	Cancer/Oncology, Women's Health	11/21/14	4/28/16
Exploring the Role of CDK4 and CDK6 in Melanoma Maintenance	Martin McMahon, PhD	Cancer/Oncology	5/1/13	4/30/16
Breast Cancer and the Environment Research Program Coordinating Center	Robert Hiatt, MD, PhD	Cancer/Oncology	9/1/10	4/30/16
International Collaborative of prospective studies of HIV and Hepatitis in IDU	Stephen Shiboski, PhD	Sexually Transmitted Infections (STIs), Cancer/Oncology	9/1/14	4/30/16
Risk-Based Screening: An Initiative to Dramatically Improve Our Approach to Screening and Prevention	Laura Esserman, MD	Cancer/Oncology	8/1/14	4/30/16
Cellular mechanisms of resistance to chemotherapy and the impact of immune modulating therapy, and molecular characterization of circulating tumor cells (CTCs) in patients with advanced breast cancer (ABC)	Hope Rugo, MD	Cancer/Oncology, Women's Health	5/21/15	5/20/16
A Phase II Trial of HKI-272 (Neratinib) for Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer and Brain Metastases (TBCRC 022)	Michelle Melisko, MD	Cancer/Oncology, Neurology and Mental Health, Women's Health	6/1/12	5/31/16
TBCRC 22: A Phase II Trial of HKI-272 (Neratinib) for Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast cancer and Brain Metastases	Michelle Melisko, MD	Cancer/Oncology, Neurology and Mental Health, Women's Health	7/11/12	5/31/16
Symptoms Clusters in Oncology Patients Receiving Chemotherapy	Christine Miaskowski, RN, PhD, FAAN	Cancer/Oncology	7/22/09	5/31/16
Kaiser Permanente Cervical Cancer Prevention (CCaP) Network	George Sawaya, MD	Cancer/Oncology, Women's Health	9/12/14	5/31/16
Master Member Agreement: Translational Breast Cancer Research Consortium	Hope Rugo, MD	Cancer/Oncology, Epidemiology and Surveillance	6/20/11	6/19/16
Maintain a Health Professional Career Opportunity Program	Renee Navarro, MD	Cancer/Oncology	6/26/15	6/24/16
131I-MIBG Imaging and Therapy for Neuroblastoma: Infrastructure Proposal	Katherine Matthay, MD	Cancer/Oncology	7/1/12	6/30/16
Non-Invasive Differentiation of Benign Lesions from Aggressive Pancreatic Cancer	Charles Craik, PhD	Cancer/Oncology	7/1/15	6/30/16
Effect of an embedded palliative care program on the unmet needs of patients with metastatic breast cancer.	Melanie Majure, MD	Cancer/Oncology, Women's Health	7/1/15	6/30/16
MR Metabolic Imaging of Response to Targeted Therapies in GBM	Sabrina Ronen, PhD	Cancer/Oncology, Drug and Diagnostics Development	9/8/11	6/30/16
The Breast Cancer Clinical Trials Consortium	Hope Rugo, MD	Cancer/Oncology, Women's Health	4/30/09	6/30/16
Personal Patient Profile - Prostate (P3P): A Randomized Multi-site Trial	Leslie Wilson, PhD, MS	Cancer/Oncology	9/4/12	6/30/16
Fatty acid transporters in cholangiocarcinoma pathogenesis	Xin Chen, PhD	Cancer/Oncology	7/1/14	6/30/16
Negative Feedback and oncogene signaling in leukemia	Markus Muschen, MD, PhD	Cancer/Oncology	7/1/14	6/30/16
Interplay between tension and inflammation in pancreatic tumor progression	Valerie Weaver, PhD	Cancer/Oncology	7/1/13	6/30/16
The Meningioma Consortium: Genome-Wide Association Study	Joseph Wiemels, PhD	Cancer/Oncology	7/1/10	6/30/16
Accurate, long-read sequencing with droplet-microfluidic barcoding	Adam Abate, PhD	Infectious Disease, Cancer/Oncology, Genetics	8/1/13	6/30/16
Exploring the Role of CDK4 and CDK6 in Melanoma Maintenance	Martin McMahon, PhD	Cancer/Oncology	6/3/13	6/30/16
Medical Scientist Training Program	Mark Anderson, MD, PhD	Noncommunicable and/or Chronic Disease, Cancer/Oncology, Dementia and Cognitive Impairment, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education	7/1/11	6/30/16
Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia	Markus Muschen, MD, PhD	Cancer/Oncology, Pediatrics	7/1/15	6/30/16
Postdoctoral training in tobacco control	Stanton Glantz, PhD	Cancer/Oncology, Smoking and Tobacco, Residencies, Fellowships, and Postdoctoral Training	8/8/11	6/30/16
Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer - Core A		Cancer/Oncology	9/1/15	6/30/16
SPORE in Head and Neck Cancer - Project 2		Cancer/Oncology	9/1/15	6/30/16
Promoting Post-Treatment Self-Management among Latinos with Cancer	Anna Napoles, PhD, MPH	Cancer/Oncology, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination	7/8/14	6/30/16
Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons	Nancy Hessol, MSPH	HIV/AIDS, Cancer/Oncology	9/14/12	6/30/16
Decision-Making about CAM Across the Cancer Continuum: An Observational Study	Barbara Koenig, PhD	Cancer/Oncology	7/1/12	6/30/16
Effects of Maraviroc on HIV-related Kaposi Sarcoma	Toby Maurer, MD	HIV/AIDS, Cancer/Oncology	7/1/11	7/21/16
The Effectiveness of Screening HIV-Infected Women for Anal Cancer Precursors	Teresa Darragh, MD	HIV/AIDS, Cancer/Oncology, Women's Health	8/1/14	7/30/16
Elucidating the Fundamental Biology of Memory Regulatory T cells in Skin		Cancer/Oncology, Immunology	8/1/14	7/31/16
Predicting Early and Late Recurrence to Improve Care	Laura Esserman, MD	Cancer/Oncology, Women's Health	6/1/13	7/31/16
Breast Cancer Surveillance Consortium Data Resource	Karla Kerlikowske, MD	Cancer/Oncology, Women's Health	8/1/11	7/31/16
Targeting the c-Met/HGF Axis in acute Myeloid Leukemia	Charalambos (Babis) Andreadis, MD	Cancer/Oncology	8/13/14	7/31/16
Epigenetic Markers of Age and Diurnal Levels of Fatigue during Chemotherapy	Kathryn Lee, RN, PhD, FAAN	Cancer/Oncology, Women's Health	9/25/15	7/31/16
The role of HDAC2 in hormone therapy resistance	Pamela Munster, MD	Cancer/Oncology	9/19/11	7/31/16
Administrative Supplements to Cancer Centers Support Grants to Stimulate Collaborative HIV Malignancy Research in Low and Middle Income Countries	Joel Palefsky, MD	HIV/AIDS, Cancer/Oncology, Women's Health	8/1/15	7/31/16
Leukocyte Biomarkers for Predicting Human Breast Cancer Outcomes	Matthew Krummel, PhD	Cancer/Oncology	3/1/12	7/31/16
Lung Cancer Screening: Development of a Clinic-Based Intervention	Celia Kaplan, DrPH	Cancer/Oncology	1/1/15	7/31/16
Clinical Investigator Research Program for Pilot Research Studies 2013	Eric Small, MD	Cancer/Oncology	7/1/13	7/31/16
The Effectiveness of Screening HIV-Infected Women for Anal Cancer Precursors	Teresa Darragh, MD	HIV/AIDS, Cancer/Oncology, Women's Health	9/19/11	7/31/16
Enhancing the Efficacy of Chemotherapy in Triple Negative/Basal-like Breast Cancer by Targeting Macrophages	Hope Rugo, MD	Cancer/Oncology	11/1/11	8/7/16
Tissue Biopsy Samples from Head and Neck Cancers	Charles Chiu, MD, PhD	Cancer/Oncology, Drug and Diagnostics Development	8/10/11	8/9/16
Risk of hematologic cancers from repeated low-dose diagnostic radiation.	Lydia Zablotska, MD, MPA, PhD	Cancer/Oncology, Occupational and Environmental Disease	9/5/14	8/31/16
Genetics of Mammographic Density in Ashkenazi Jews	Elad Ziv, MD	Cancer/Oncology, Genetics	9/15/13	8/31/16
Genome wide association study of breast cancer subtype and survival in Latinas	Laura Fejerman, PhD	Cancer/Oncology, Genetics, Epidemiology and Surveillance	9/23/11	8/31/16
Characterization of and Treatment for Chemotherapy Neuropathy	Christine Miaskowski, RN, PhD, FAAN	Cancer/Oncology, Neurology and Mental Health	9/9/11	8/31/16
Risk-Based Breast Cancer Screening in Community Settings	Karla Kerlikowske, MD	Cancer/Oncology, Women's Health	9/27/11	8/31/16
Microtubule Complexes Involved in Intracellular Transport	Ronald Vale, PhD	Cancer/Oncology	9/1/11	8/31/16
Regulation and Targets of the DNA Damage Checkpoint	David Toczyski, PhD	Cancer/Oncology	9/1/12	8/31/16
Modeling Juvenile Myelomonocytic Leukemia with Patient-Derived Induced Pluripotent Stem Cells	Mignon Loh, MD	Cancer/Oncology, Adolescent Health	9/1/14	8/31/16
Comparative Effectiveness of Antiretroviral Therapy (ART) with Upfront Chemotherapy versus ART Alone in HIV-Infected Patients with Kaposi Sarcoma without Urgent Indications for Chemotherapy	Jackie (Chia-Ching) Wang, MD	HIV/AIDS, Opportunistic Infection, Cancer/Oncology, Pharmacology and Drug Treatment	9/1/15	8/31/16
PRESENT: Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment	Michelle Melisko, MD	Cancer/Oncology, Women's Health	9/25/12	9/25/16
Pancreatic Cancer Research Pilot Project	Margaret Tempero, MD	Cancer/Oncology	10/1/15	9/30/16
HPV testing of samples from the AIDS Malignancy Consortium	Joel Palefsky, MD	HIV/AIDS, Opportunistic Infection, Cancer/Oncology	10/1/15	9/30/16
Pharmacological hyperactivation of Ras-MAPK signaling to target Ph+ ALL	Markus Muschen, MD, PhD	Cancer/Oncology, Pediatrics	10/1/13	9/30/16
Evaluation of Pomalidomide in Combination with High Dose Dexamethasone and Oral Cyclophosphamide in Patients with Relapsed and Refractory Myeloma	Thomas Martin, MD	Cancer/Oncology, Pharmacology and Drug Treatment	10/1/12	10/1/16
Evaluation of Pao Pereira, a natural product of the extract of rainforest tree, in malignant brain tumor cell lines	Nicholas Butowski, MD	Cancer/Oncology, Drug and Diagnostics Development	10/3/14	10/2/16
Deep Sequencing Recessive Dystrophic Epidermolysis Bullosa Squamous Cell Carcinoma	Raymond Cho, MD, PhD	Cancer/Oncology	10/5/15	10/4/16
Phase II study of letrozole with or without BYL719 or buparlisib, for the neoadjuvant treatment of postmenopausal women with hormone receptor-positive HER2-negative breast cancer	Hope Rugo, MD	Cancer/Oncology	9/16/13	11/12/16
A Causal Role for Asymmetric Cell Division Defects in Glioma Initiation	Claudia Petritsch, PhD	Noncommunicable and/or Chronic Disease, Cancer/Oncology	12/13/11	11/30/16
Influence of germ line genetic variation on myeloma progression and survival	Elad Ziv, MD	Cancer/Oncology	12/15/14	11/30/16
PRE-VIEW An Interactive Video Doctor to Encourage Cancer Screening	Judith Walsh-Cassidy, MD, MPH	Cancer/Oncology, Access or Barriers to Care, Patient and Peer Education	12/1/15	11/30/16
Study of the histone deacetylase inhibitor Panobinostat (LBH589) in combination with standard dose Cytarabine and Daunorubicin for older patients with untreated acute Mmyeloid leukemia or advanced myelodysplasia	Charalambos (Babis) Andreadis, MD	Cancer/Oncology	10/31/11	12/31/16
Prostate Cancer Therapeutic Clinical Investigation "First in Man"	Eric Small, MD	Cancer/Oncology, Drug and Diagnostics Development	1/1/09	12/31/16
Mechanisms and Therapeutics for Glucocorticoid-Resistant Leukemia	Keith Yamamoto, PhD	Cancer/Oncology	1/1/13	12/31/16
Breast Cancer Screening and Outcomes in Diverse Populations: Role of Comorbidity		Cancer/Oncology, Women's Health	1/1/12	12/31/16
CAPTC - Institute for Human Virology - Nigeria (IHVN) Partner Testing Services	Michael Policar, MD, MPH	Cancer/Oncology	9/26/16	12/31/16
Molecular genetic, host-derived and clinical determinants of long-term survival in glioblastoma	Jennifer Clarke, MD, MPH	Cancer/Oncology, Genetics	1/1/15	12/31/16
Three Center Symposium		Cancer/Oncology	1/1/07	12/31/16
Identifying neurofibromin-specific regulatory nodes for therapeutic targeting in NF1	Frank McCormick, PhD, FRS	Cancer/Oncology	1/1/16	12/31/16
Cutting Edge Lineage Tracking of Tumor-Educated Immune Cells	Matthew Krummel, PhD	Cancer/Oncology	1/1/15	12/31/16
Dar es Salaam ESCC Case-Control Study	Katherine Van Loon Steitz, MD, MPH	Cancer/Oncology	1/1/16	12/31/16
Rational Combined Inhibition of NF-kB and EGFR to Optimize Lung Cancer Treatment	Trever Bivona, MD, PhD	Cancer/Oncology, Chronic Respiratory Disease	2/1/16	1/31/17
Identification of the SNPs and their Interaction with environmental factors in Esophageal Cancer in Tanzania	Li Zhang, PhD	Cancer/Oncology, Occupational and Environmental Disease	2/15/16	2/15/17
Tumor Recurrence and Drug Resistance in Non-Small Cell Lung Cancer Through Modulation of the Cytoskeleton and Activation of YAP		Cancer/Oncology	3/1/16	2/28/17
Using Comparative Effectiveness Analyses to Optimize Cervical Cancer Screening	George Sawaya, MD	Cancer/Oncology	3/8/13	2/28/17
A Randomized Phase 2 Study of Cabozantinib (XL184) in Combination with Abiraterone in Chemotherapy Naïve Subjects with Bone-Metastatic Castration-Resistant Prostate Cancer	Charles Ryan, MD	Cancer/Oncology	3/28/14	3/28/17
An Open-Label, Multicenter Extension Study of Trastuzumab-MCC-DM1 in Patients Previously Treated with T-DM1 in a Genentech-Sponsored T-DM1 Study	Hope Rugo, MD	Cancer/Oncology, Women's Health	1/27/09	4/1/17
Serum Androgens as Predictors of Survival in Metastatic Prostate Cancer	Charles Ryan, MD	Cancer/Oncology	5/5/15	4/30/17
Advanced Methods to Evaluate Extracellular Matrix and Crosslinking in the Tumor Microenvironment	Valerie Weaver, PhD	Cancer/Oncology	5/2/14	4/30/17
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 with Letrozole in Adult Patients with Advanced ER+ Breast Cancer	Pamela Munster, MD	Cancer/Oncology, Women's Health	10/21/13	4/30/17
Genetic network analysis of cancer targets	William Weiss, MD, PhD	Cancer/Oncology	4/1/13	4/30/17
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI	Daniel Vigneron, PhD	Cancer/Oncology	7/15/13	5/31/17
Engaging Underserved Women in Health Research	Galen Joseph, PhD	Cancer/Oncology, Women's Health	6/1/14	5/31/17
A Phase 2 Pilot Feasibility Study of Palbociclib in Combination with Adjuvant Endocrine Therapy for Hormone Receptor Positive Invasive Breast Carcinoma.	Hope Rugo, MD	Cancer/Oncology, Women's Health	5/11/15	5/31/17
Randomized Trial to Increase Adherence to Cervical Cancer Screening Guidelines for Young Women	Anna-Barbara Moscicki, MD	Cancer/Oncology, Women's Health	7/1/14	6/30/17
The PROMOTE Program: Precision Oncology and Molecular Targeting in Advanced Prostate Cancer Advancing the Promise of the PCF/SU2C/AACR West Coast Prostate Cancer Dream Team	Eric Small, MD	Cancer/Oncology	6/1/15	6/30/17
Murine Neuroblastoma Models for Preclinical Therapeutics	William Weiss, MD, PhD	Cancer/Oncology, Drug and Diagnostics Development	9/1/12	6/30/17
University of California Global Health Institute Program for Fellows and Scholars	Craig Cohen, MD, MPH	Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training	7/1/15	6/30/17
(PQC4) Fate of cells disseminating from human breast cancer xenografts	Zena Werb, PhD	Cancer/Oncology, Risk Reduction and Prevention	8/1/13	6/30/17
CC#14952: Phase IB Study of MK-3475 in Subjects with Select Advanced Solid Tumors	Hope Rugo, MD	Cancer/Oncology, Pharmacology and Drug Treatment	3/1/14	6/30/17
Clinical Investigator Research Program for Pilot Research	Eric Small, MD	Cancer/Oncology	8/1/15	7/31/17
Genetic and Epidemiological Approaches to Breast Density and Breast Cancer Risk	Elad Ziv, MD	Cancer/Oncology, Women's Health	8/9/12	7/31/17
Genetic Susceptibility to Pediatric Glioma in Individuals and Diverse populations	Joseph Wiemels, PhD	Cancer/Oncology, Pediatrics	7/13/15	7/31/17
CARAVAN: Checkpoint-Radiation-Vaccine Neoadjuvant Trial for Metastatic Prostate Cancer	Lawrence Fong, MD	Cancer/Oncology	7/31/15	7/31/17
East Africa IEDEA Regional Consortium	Craig Cohen, MD, MPH	HIV/AIDS, Tuberculosis, Cancer/Oncology, Epidemiology and Surveillance	8/1/16	7/31/17
Natural History of HPV in Teens-Infection to Neoplasia	Stephen Shiboski, PhD	Sexually Transmitted Infections (STIs), Cancer/Oncology, Adolescent Health	8/1/15	7/31/17
Evaluation of technetium Tc 99m tilmanocept (Lymphoseek) Localization, Retention, and Distribution in Primary Cutaneous Kaposi's Sarcoma (KS) and Lymphatic Drainage from KS Lesions by SPECT and SPECT/CT Imaging	Toby Maurer, MD	HIV/AIDS, Cancer/Oncology, Pharmacology and Drug Treatment	8/20/14	8/19/17
Translating Cancer Genetics for the Safety Net Setting	Galen Joseph, PhD	Cancer/Oncology, Genetics, Women's Health	8/24/12	8/23/17
Real-World Treatment Patterns and Associated Outcomes Among Patients with Advanced Progressive Pancreatic Neuroendocrine Tumors	Emily Bergsland, MD	Cancer/Oncology	7/1/14	8/30/17
Comparative Effectiveness of Breast Cancer Screening, Diagnosis, and Management in Community Practice	Karla Kerlikowske, MD	Cancer/Oncology, Women's Health	9/1/16	8/31/17
Molecular Genetics of Liver Cancers	Xin Chen, PhD	Cancer/Oncology, Genetics	9/8/14	8/31/17
The Role of PD-1 Pathway and Tissue Microenvironment in HIV-Kaposi Sarcoma and Endemic Kaposi Sarcoma Cohort in Western Kenya	Toby Maurer, MD	HIV/AIDS, Cancer/Oncology	9/1/15	8/31/17
Enabling a Paradigm Shift: A Preference-Tolerant RCT of Personalized vs. Annual Screening for Breast Cancer	Laura Esserman, MD	Cancer/Oncology, Women's Health	9/1/14	8/31/17
Obesity, Body Fat Distribution and Cancer Risk in the Multiethnic Cohort (Core C)	John Shepherd, PhD	Cancer/Oncology, Diet, Exercise, and Obesity	9/1/12	8/31/17
Treatment Decision Making Involvement in Adolescents and Young Adults With Cancer	Kimberly A. Pyke-Grimm, RN, MN, CNS	Cancer/Oncology, Adolescent Health	9/1/15	8/31/17
BRAF Mutation in Malignant Astrocytoma Origin, Evolution, and Response to Therapy	Claudia Petritsch, PhD	Cancer/Oncology	9/1/14	8/31/17
UCSF-GIVI Center for AIDS Research (CFAR)	Paul Volberding, MD	HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Drug and Diagnostics Development, Immunology, Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD, Women's Health, Pediatrics, Implementation and Behavioral Science, Training and Capacity Building, Training International Scholars and Clinicians	9/1/12	8/31/17
Probing Tumor Metastasis through Chemical Cell Surface Engineering	Valerie Weaver, PhD	Cancer/Oncology, Immunology	9/1/13	8/31/17
Translational development of a novel antibody-drug conjugates against myeloma	Bin Liu, PhD	Cancer/Oncology, Immunology	10/1/15	9/30/17
The Breast Cancer Clinical Trials Consortium	Hope Rugo, MD	Cancer/Oncology, Women's Health	5/1/09	9/30/17
Improving outcomes for JMML (juvenile myelomonocytic leukaemia) through targeted therapeutics	Mignon Loh, MD	Cancer/Oncology, Pediatrics	10/1/14	9/30/17
Monitoring Physical Activity During Chemotherapy Among Breast Cancer Patients: A Needs Assessment to Develop Interventions to Help Prevent Functional Decline	Laura Esserman, MD	Cancer/Oncology, Women's Health	9/15/15	10/31/17
A Phase III, Open-Label, Randomized Study of MPDL3280A (Anti-PD-L1 Antibody) in Combination with Bevacizumab versus Sunitinib in Patients with Untreated Advanced Renal Cell Carcinoma	Lawrence Fong, MD	Cancer/Oncology	10/30/15	11/1/17
Molecular Mechanisms Underlying Tumor Progression Despite Enzalutamide Treatment	Eric Small, MD	Cancer/Oncology, Pharmacology and Drug Treatment	11/20/15	11/19/17
Targeting MYC-Driven Cell Cycle Progression in Neuroendocrine Prostate Cancer with Gallium Citrate PET as a Novel Biomarker of MYC Transcriptional Activity	Rahul Aggarwal, MD	Cancer/Oncology, Drug and Diagnostics Development	12/1/15	11/30/17
Phase III Study Evaluating Palbociclib (PD-0332991), a Cycline-Dependent Kinase (CDK) 4/6 Inhibitor in Patients with Hormone-Receptor-Positive, HER2-Normal Primary Breast Cancer with High Relapse Risk after Neoadjuvant Chemotherapy "Penelope"	Hope Rugo, MD	Cancer/Oncology, Women's Health	12/1/15	11/30/17
Modular phase II study to link targeted therapy to patients with pathway activated tumors: Module 6 - BGJ398 for patients with tumors with FGFR genetic alterations	Jackie (Chia-Ching) Wang, MD	Cancer/Oncology	4/11/16	12/31/17
New ways of treating pancreatic cancer based on reversing K-Ras-mediated stemness	Frank McCormick, PhD, FRS	Cancer/Oncology, Immunology	1/1/15	12/31/17
Hedgehog signaling and signal transduction	Thomas Kornberg, PhD	Cancer/Oncology	11/1/13	12/31/17
New Paradigm of Breat Cancer Causation and Prevention - Phase II	Robert Hiatt, MD, PhD	Cancer/Oncology, Occupational and Environmental Disease, Women's Health	1/15/15	1/14/18
Metabolic Reprogramming in Brain Tumors	Sabrina Ronen, PhD	Cancer/Oncology	2/5/13	1/31/18
A Phase II, Open Study of the Clinical Activity, Safety and Tolerability of Lapatinib in Combination with Bevacizumab in Subjects with Advanced or Metastatic ErbB-2-Overexpressing Breast Cancer	Hope Rugo, MD	Cancer/Oncology, Women's Health	2/16/07	2/15/18
Identifying Human Breast Carcinogens Using Exposomics (2)	Laura Fejerman, PhD	Cancer/Oncology, Women's Health	3/1/15	2/28/18
Study of Paclitaxel eith GDC-0941 vs Paclicaxel with placebo in patients with locally recurrent or Metastatic Breast Cancer	Michelle Melisko, MD	Cancer/Oncology, Women's Health	3/1/13	2/28/18
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis	John Shepherd, PhD	Noncommunicable and/or Chronic Disease, Cancer/Oncology, Risk Reduction and Prevention	3/6/13	2/28/18
Molecular Methods for Cervical Cancer Screening in HIV+ Women	Nancy Hessol, MSPH	Cancer/Oncology, Drug and Diagnostics Development, Women's Health	5/1/13	3/31/18
Targeting Oncogenic BRAF And PI3'-Kinase Signaling For Melanoma Therapy	Martin McMahon, PhD	Cancer/Oncology	4/1/13	3/31/18
The Prostate Cancer Clinical Trials Consortium: Clinical Research Site Application	Charles Ryan, MD	Cancer/Oncology	4/15/15	4/14/18
Phase II Study of MK-3475 with and without Bevacizumab for Recurrent Glioblastoma	Jennifer Clarke, MD, MPH	Cancer/Oncology, Pharmacology and Drug Treatment	10/18/15	4/28/18
Negative feedback signaling in tyrosine kinase-driven leukemia	Markus Muschen, MD, PhD	Cancer/Oncology	7/1/13	4/30/18
Targeting BCL6 in tyrosine kinase-driven leukemia	Markus Muschen, MD, PhD	Cancer/Oncology	5/15/13	4/30/18
Three Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)	Alan Venook, MD	Cancer/Oncology, Drug and Diagnostics Development, Pharmacology and Drug Treatment	5/21/13	5/20/18
PNOC-002: Safety, Phase 0, and Pilot Efficacy Study of vemurafenib, an oral inhibitor of BRAFV600E, in Children with Recurrent/Refractory BRAFV600E-mutant gliomas	Michael Prados, MD	Cancer/Oncology, Pharmacology and Drug Treatment, Pediatrics	5/31/13	5/30/18
(PQ5) Role of HIV-associated cellular miRNAs in HPV 16-induced pathogenesis	Joel Palefsky, MD	Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology	6/1/16	5/31/18
Randomized Controlled Trial of the Effect of the Livongo Health Diabetes Management Program vs. Standard Care on Glycemic Control	Jeffrey Olgin, MD	Cancer/Oncology	3/1/17	6/30/18
Metastatic escape mechanisms in TKI resistant lung cancer		Cancer/Oncology	7/1/15	6/30/18
Management of esophageal cancer in East Africa: a prospective cohort study of treatment strategies and supportive care	Geoffrey Buckle, MD, MPH	Noncommunicable and/or Chronic Disease, Cancer/Oncology	7/1/17	6/30/18
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment	Peter Hunt, MD	HIV/AIDS, Cancer/Oncology, Cardiovascular Disease, Aging	9/1/15	6/30/18
Head and Neck Cancer as a Model for Bedside-to-Bench Research		Cancer/Oncology	2/1/15	6/30/18
Randomized Trial to Increase Adherence to Cervical Cancer Screening Guidelines for Young Women (UCSF sub-in)	Heike De Bocanegra, MPH, PhD	Cancer/Oncology, Women's Health	7/1/15	6/30/18
Physical and Genetic Interaction Landscape of the Tyrosine Kinome	Nevan Krogan, PhD, MSc	Cancer/Oncology, Diabetes, Immunology	9/1/14	6/30/18
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect	Jeffrey Martin, MD, MPH	HIV/AIDS, Cancer/Oncology, Drug and Diagnostics Development	8/17/16	7/31/18
Perinatal Immune Development and Risk of Childhood Acute Lymphoblastic Leukemia	Joseph Wiemels, PhD	Cancer/Oncology, Pediatrics	8/1/14	7/31/18
DLM-10-001: An Open-Label, Single Arm, Safety and Tolerability Dose-escalation Study of DAG in Patients with Recurrent Malignant Glioma or Progressive Secondary Brain Tumor	Nicholas Butowski, MD	Cancer/Oncology	7/15/13	7/31/18
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study of ARN-509 in Men with Non-Metastatic (M0) Castration-Resistant Prostate Cancer	Eric Small, MD	Cancer/Oncology	12/11/13	7/31/18
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods	Daniel Vigneron, PhD	Cancer/Oncology	8/1/16	7/31/18
A Phase I/II Study Evaluating Microwave Hyperthermia and Thermodox (Lyso-Thermosensitive Liposomal Doxorubicin) in Patients with Breast Cancer Recurrence at the Chest Wall (DIGNITY)	Hope Rugo, MD	Cancer/Oncology, Women's Health	3/10/10	7/31/18
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods	Daniel Vigneron, PhD	Cancer/Oncology	8/15/13	7/31/18
Caring in and Beyond the Clinic; Development of a Community-based Care Navigation Program for Radiation Oncology	Galen Joseph, PhD	Cancer/Oncology, Patient and Peer Education	2/1/16	7/31/18
Exome sequencing in Diverse Populations in Colorado & Oregon	Galen Joseph, PhD	Cancer/Oncology, Drug and Diagnostics Development, Access or Barriers to Care	8/1/17	7/31/18
HIV/HPV cancer prevention treatment and pathogenesis: Rwanda /Einstein Consortium	Joel Palefsky, MD	HIV/AIDS, Opportunistic Infection, Cancer/Oncology	8/10/15	8/10/18
Mechanism regulating ErbB signaling network in head and neck cancer	Randall Kramer, PhD	Cancer/Oncology, Immunology	12/1/15	8/31/18
Influencing cervical cancer prevention and detection online through social media	Urmimala Sarkar, MD	Cancer/Oncology, Women's Health	9/22/14	8/31/18
Exposomic approach to understand the effect of immigration and genetic ancestry on breast cancer risk in U.S. Latinas	Laura Fejerman, PhD	Cancer/Oncology, Occupational and Environmental Disease	9/1/16	8/31/18
Automated Density Measures for Estimating Breast Cancer Risk and Therapy Response	Karla Kerlikowske, MD	Cancer/Oncology	9/1/13	8/31/18
Modeling to Improve Prostate Cancer Outcomes Across Diverse Populations	Matthew Cooperberg, MD	Cancer/Oncology, Pharmacology and Drug Treatment	9/1/15	8/31/18
Evaluating a Community-Driven Cervical Cancer Prevention program in Western Kenya	Robert Hiatt, MD, PhD	Cancer/Oncology	9/1/16	8/31/18
UCSF CT Radiation Dose Registry to Ensure a Patient Centered Approach for Imaging	Rebecca Smith-Bindman, MD	Cancer/Oncology, Epidemiology and Surveillance, Risk Reduction and Prevention	10/1/13	9/21/18
Elucidating the molecular and contextual basis for IDLE ultralow risk lesions and the tumor immune microenvironment of high risk in situ and invasive breast cancers	Laura Esserman, MD	Cancer/Oncology, Women's Health	9/30/15	9/29/18
A Biophysical Perspective of Breast Cancer Metastasis and Treatment Resistance	Valerie Weaver, PhD	Cancer/Oncology, Women's Health	9/30/13	9/29/18
Targeting KRAS Mutant Lung Cancers	Frank McCormick, PhD, FRS	Cancer/Oncology	10/5/15	10/5/18
Prostate Cancer Foundation Young Investigator Award		Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training	10/12/15	10/12/18
Hepatitis C Therapeutic Registry and Research Network (HCV-TARGET)	Kathleen Tebb, PhD	Infectious Disease, Cancer/Oncology	10/24/12	10/25/18
A Novel Targeted Therapy for Medulloblastoma	Jeremy Reiter, MD, PhD	Cancer/Oncology	11/1/15	10/31/18
Association Between Long-Term Ultrafine Particulate Matter Exposure and Premature Death	Peggy J. Reynolds, PhD, MPH, MA	Cancer/Oncology, Occupational and Environmental Disease	5/1/18	10/31/18
Testing Targeted Therapy in Philadelphia Chromosome-Like (Ph-Like) All	Mignon Loh, MD	Cancer/Oncology, Drug and Diagnostics Development	7/1/13	10/31/18
A Randomized Phase 2 Trial of Immediate vs. Delayed Anti-Ctla4 Blockade Following Sipuleucel-T Treatment for Prostate Cancer Immunotherapy	Lawrence Fong, MD	Cancer/Oncology, Pharmacology and Drug Treatment	6/5/13	11/11/18
An Open Label, Multicenter, Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer	Charles Ryan, MD	Cancer/Oncology	11/22/13	11/21/18
Service Agreement - HALO-109-301 Study	Margaret Tempero, MD	Cancer/Oncology, Pharmacology and Drug Treatment	11/30/15	11/30/18
ANCHOR (Anal Cancer/HSIL Outcomes Research) Study (AMC Supplement Administrative Core)	Joel Palefsky, MD	Cancer/Oncology	12/1/15	11/30/18
BGJ398X2201 - A Phase 2, multicenter, open-label study of BGJ398 in patients with recurrent resectable or unresectable Glioblastoma	Nicholas Butowski, MD	Cancer/Oncology	12/23/13	12/1/18
A Single Arm, Open-Label, Phase 2 Study of MGAH22 (Fc-Optimized Chimeric Anti-HER2 Monoclonal Antibody) in Patients with Relapsed or Refractory Advanced Breast Cancer Whose Tumors Express HER2 at the 2+ Level by Immunohistochemistry and Lack Evidence	Hope Rugo, MD	Cancer/Oncology	2/12/13	12/6/18
An Open-label, Multi-center, Extension Study of NKTR 102 in Subjects Previously Enrolled in NKTR-102 Studies	Pamela Munster, MD	Cancer/Oncology	12/12/13	12/11/18
The goal of this clinical trial is to show that incorporating ofatumumab instead of rituximab in combination with etoposide and cytarabine (OVA) is successful in collecting autologous stem cells for use in an autologous stem cell transplantation (autoSCT)	Charalambos (Babis) Andreadis, MD	Cancer/Oncology	5/15/12	12/15/18
Development of a PET prostate specific membrane antigen imaging agent: Preclinical translation	Henry Vanbrocklin, PhD	Cancer/Oncology	9/30/14	12/31/18
Natural History of HPV in Teens-Infection to Neoplasia	Stephen Shiboski, PhD	Sexually Transmitted Infections (STIs), Cancer/Oncology, Adolescent Health	1/1/16	12/31/18
The Microbiome and Anal Cancer Pathogenesis in HIV-infected Men who have Sex with Men	Joel Palefsky, MD	Infectious Disease, HIV/AIDS, Cancer/Oncology	1/13/17	12/31/18
Comorbidity and screening outcomes among older women undergoing mammography	Karla Kerlikowske, MD	Cancer/Oncology, Women's Health	1/1/18	12/31/18
A Phase 1b/2 Study of the Oral CDK4/6 Inhibitor LEE011 in Combination with Docetaxel plus Prednisone in Metastatic Castration Resistant Prostate Cancer	Rahul Aggarwal, MD	Cancer/Oncology, Pharmacology and Drug Treatment	8/24/15	12/31/18
The Mechanistic Effects of Th2 and Th17 Lung Inflammation on Metastasis	Stephen Jones, PhD	Cancer/Oncology, Chronic Respiratory Disease	1/1/16	12/31/18
Phase 3 study of PD-0332991 (Oral CDK4/6 inhibitor) plus Letrozole versus placebo plus Letrozole for postmenopausal women with ER (+), HER2 (-) breast cancer who have not received prior systemic anti cancer therapies	Hope Rugo, MD	Cancer/Oncology, Women's Health	4/19/13	1/3/19

Global Research Projects

Search form

You are here

Cancer/Oncology

Active Projects: 138

Active Projects: 388

Active Investigators: 74